Ordinary Adjustment | Solactive China Healthcare Disruption Index | Effective Date 3rd March 2025
Solactive China Healthcare Disruption Index:
In the ordinary adjustment, the following composition was implemented effective open 3rd March 2025:
| HUTCHMED CHINA LTD | 0.41% |
| ALIBABA HEALTH INFORMATION TECHNOLOGY LTD | 8.00% |
| SIHUAN PHARMACEUTICAL HLDGS GRP ORD | 0.13% |
| GRAND PHARMACEUTICAL GROUP LTD | 0.36% |
| CHINA MEDICAL SYSTEM HOLDINGS LTD | 0.41% |
| CSPC PHARMACEUTICAL GROUP LTD | 8.00% |
| SINO BIOPHARMACEUTICAL LTD ORD | 8.00% |
| LIVZON PHARMACEUTICAL GROUP INC | 5.08% |
| GENSCRIPT BIOTECH CORP | 4.15% |
| YICHANG HEC CHANGJIANG PHA-H | 0.99% |
| ASCLETIS PHARMA INC | 0.09% |
| INNOVENT BIOLOGICS INC | 8.00% |
| SHANGHAI JUNSHI BIOSCIENCES CO LTD | 4.17% |
| SIMCERE PHARMACEUTICAL GROUP | 0.38% |
| HBM HOLDINGS LTD | 0.07% |
| LEPU BIOPHARMA CO LTD-H | 0.11% |
| KEYMED BIOSCIENCES INC | 0.21% |
| LUYE PHARMA GROUP LTD | 0.19% |
| SHANGHAI FOSUN PHARMACEUTICAL GROUP CO LTD | 8.00% |
| SHANGHAI MICROPORT MEDBOT GR | 3.11% |
| WUXI BIOLOGICS CAYMAN INC | 8.00% |
| WUXI APPTEC CO LTD | 8.00% |
| SHANGHAI PHARMACEUTICALS HOLDING CO LTD-H | 0.50% |
| SHANGHAI HENLIUS BIOTECH INC | 0.08% |
| CHINA RESOURCES PHARMACEUTICAL | 5.50% |
| HANSOH PHARMACEUTICAL GROUP CO | 8.00% |
| PHARMARON BEIJING CO LTD-H | 0.50% |
| SKB BIO-B ORD H | 0.50% |
| ZAI LAB LTD | 0.50% |
| AKESO INC | 8.00% |
| ALPHAMAB ONCOLOGY | 0.08% |
| REMEGEN CO LTD-H | 0.32% |
| KANGJI MEDICAL HOLDINGS LTD | 0.17% |